We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.17B
AUM Growth
-$939M
Cap. Flow
-$328M
Cap. Flow %
-6.34%
Top 10 Hldgs %
49.51%
Holding
202
New
57
Increased
36
Reduced
26
Closed
61

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$121M
2
PTCT icon
PTC Therapeutics
PTCT
+$81.6M
3
VTRS icon
Viatris
VTRS
+$76.4M
4
TGT icon
Target
TGT
+$69.6M
5
FIVE icon
Five Below
FIVE
+$60.3M

Top Sells

Rank Stock Value
1
ASO icon
Academy Sports + Outdoors
ASO
+$66.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$62.3M
3
ULTA icon
Ulta Beauty
ULTA
+$62.1M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$59.8M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 45.3%
2 Consumer Staples 9.22%
3 Consumer Discretionary 6.86%
4 Technology 3.5%
5 Communication Services 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARAV
101
DELISTED
Aravive, Inc. Common Stock
ARAV
$1.8M 0.03%
+934,975
New +$2.01M
TENX icon
102
Tenax Therapeutics
TENX
$498M
$1.64M 0.03%
1,262
– –
SBFM
103
Sunshine Biopharma
SBFM
$3.33M
$1.56M 0.03%
+32
New +$1.56M
OG
104
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$1.53M 0.03%
943,390
– –
HTGM
105
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$1.16M 0.02%
+69,505
New +$2.23M
BOLT icon
106
Bolt Biotherapeutics
BOLT
$7.44M
$1.1M 0.02%
+20,000
New +$1.35M
BNBX
107
DELISTED
BNB PLUS CORP
BNBX
$984K 0.02%
+31
New +$1.39M
AGRX
108
DELISTED
Agile Therapeutics
AGRX
$953K 0.02%
+2,274
New +$1.45M
TCBPW
109
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$922K 0.02%
+1,882,352
New +$875K
SBEV.WS
110
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$904K 0.02%
904,000
– –
SBFMW
111
Sunshine Biopharma Inc Warrant
SBFMW
$876K 0.02%
+884,600
New +$617K
NERV icon
112
Minerva Neurosciences
NERV
$207M
$850K 0.02%
128,000
– –
RVSNW icon
113
Rail Vision Ltd Warrant
RVSNW
$736K
$828K 0.02%
+1,089,500
New +$828K
TTNP
114
DELISTED
Titan Pharmaceuticals
TTNP
$826K 0.02%
+43,176
New +$897K
SNAX
115
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$817K 0.02%
+43,579
New +$1.69M
GMBLZ
116
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$729K 0.01%
+2,700,000
New +$738K
DRCTW
117
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$648K 0.01%
+900,000
New +$506K
FGIWW
118
FGI Industries Warrant
FGIWW
$225K
$616K 0.01%
+933,333
New +$636K
GOVX icon
119
GeoVax Labs
GOVX
$3.76M
$500K 0.01%
+1,160
New +$922K
GMVDW
120
DELISTED
G Medical Innovations Holdings Ltd. Warrants
GMVDW
$500K 0.01%
1,000,000
– –
BNCWW
121
CEA Industries Inc Warrant
BNCWW
$44.7K
$469K 0.01%
+700,000
New +$366K
MDGSW
122
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$386K 0.01%
1,285,715
– –
MTEKW icon
123
Maris-Tech Ltd Warrants
MTEKW
$372K 0.01%
+1,261,058
New +$452K
DBGIW
124
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
$362K 0.01%
7,229
– –
AGRIW
125
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$354K 0.01%
600,000
– –
3 4
5
6 7

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Armistice Capital held 202 positions worth $5.17B, down 15% from $6.11B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital withdrew a net $328M in Q1 2022, closing 61 positions and reducing 26 holdings. Its most notable exit was Academy Sports + Outdoors, an estimated $66.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in Home Depot worth $105M.

  • Armistice Capital's largest Q1 2022 buy was Home Depot: 349,897 shares worth $105M.
  • Armistice Capital added most to PTC Therapeutics in Q1 2022, an estimated $81.6M increase.
  • Armistice Capital's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $62.3M.
  • Armistice Capital fully exited Academy Sports + Outdoors in Q1 2022, selling an estimated $66.3M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.17B portfolio in Q1 2022.
  • Armistice Capital opened 57 new positions and closed 61 in Q1 2022.
  • Armistice Capital's portfolio value fell 15% quarter-over-quarter to $5.17B.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.